Realities of newer beta-blockers for the management of hypertension.

  title={Realities of newer beta-blockers for the management of hypertension.},
  author={Camila Margarita Manrique and Thomas D. Giles and Keith C Ferdinand and James R. Sowers},
  journal={Journal of clinical hypertension},
  volume={11 7},
Beta-blockers are prescribed for a variety of cardiovascular conditions including hypertension, heart failure, primary treatment of myocardial infarction (MI), and secondary prevention of ischemic cardiac events. Yet they remain underprescribed in populations at increased risk for cardiovascular disease because of tolerability and safety concerns. Beta-blockers are heterogeneous with respect to pharmacokinetic and pharmacodynamic effects. "Original" agents were nonselective, blocking both beta1… CONTINUE READING


Publications citing this paper.

Similar Papers

Loading similar papers…